SCF/c-kit Ligand Antibody (371907) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2268B

Conjugate
Catalog #
Key Product Details
Species Reactivity
Canine, Feline
Applications
Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # 371907
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant canine SCF/c‑kit Ligand
Lys26-Ala190
Accession # Q06220
Lys26-Ala190
Accession # Q06220
Specificity
Detects canine and feline SCF/c‑kit Ligand in direct ELISAs and Western blots. In direct ELISAs and Western blots, 50%‑100% cross‑reactivity with recombinant human (rh) SCF and recombinant mouse SCF is observed and no cross-reactivity with rhM-CSF is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for SCF/c-kit Ligand Antibody (371907) [Biotin]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SCF/c-kit Ligand
Long Name
Stem Cell Factor
Alternate Names
c-kit Ligand, DCUA, DFNA69, FPH2, FPHH, KITLG, KL-1, MGF, SHEP7, SLF
Gene Symbol
KITLG
Additional SCF/c-kit Ligand Products
Product Documents for SCF/c-kit Ligand Antibody (371907) [Biotin]
Product Specific Notices for SCF/c-kit Ligand Antibody (371907) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...